medigraphic.com
Órgano Oficial de el Colegio Mexicano de Urología

2005, Number 2

<< Back Next >>

Bol Col Mex Urol 2005; 20 (2)

1st National Consensus Meeting on the Antimicrobial Management of Urinary Tract Infections IVU's in adults

Barragán AIA, Barriga AG, Calderón FF, Casasola GJI, Francolugo VVA, Jamaica VE, Medina OA, Morales MJG, Morfín OR, Rodríguez GL, Zavala TIG

Language: Spanish
References: 23
Page: 46-57
PDF size: 149.81 Kb.


ABSTRACT

Urinary tract infections are called IVU’s in Mexico because of the Spanish contraction for urinary tract infections, and are an important national health problem in this and other countries, bearing a significant incidence and an important mortality rate that could be diminished by developing a suitable clinical management, because most of the deaths are due to complicated cases and a poor clinical management. Looking for solutions, a group of Mexican specialists gathered in Huatulco, Oaxaca, from the 7th through the 10th of October 2004 with the aim of carrying along the “lst National Consensus Meeting on the Antimicrobial Management of UTI’s –IVUs- in the Adult”. The meeting opened a chance for discussing several aspects regarding the definition, diagnosis and treatment of these infections, focusing infections with a bacterial etiology, because they are, by far, the most common ones and reviewing the capital related topics like antimicrobial activity and bacterial resistance. This discussion forum was carried out at the light of the most internationally updated clinical criteria and guidelines, aiming to adapt them to the Mexican circumstance and specific needs, in order to impinge in a positive way on the national epidemics. This report gives us the achieved consensus concepts, criteria and therapeutic guidelines – basically on the use of antimicrobial agents – considered as the more promising & suitable ones for the medical management of “IVUs” in Mexico.


REFERENCES

  1. Stamm WE. Urinary Tract Infections And Pyelonephritis. Harrison. Principles of Internal Medicine. 15th Edition, Vol 2: 1620-1625.

  2. Liss P-E, Aspevall O, Karlsson D, Forsum U. Terms used to describe urinary tract infections – the importance of conceptual clarification. Apmis Volume 111 Issue 2 Page 291 – February 2003 doi:10..1034/j. 1600-0463.2003. 1110201 .x

  3. Fitzgerald MA, Lie D, Nettina SM. Urinary Tract Infection: Providing the Best Care. http://www.medscape.com/viewprogram/1920pnt

  4. Wilson ML, Gaido L. Medical Microbiology. Clin Infec Dis 2004; (38): 1150-57.

  5. Campbell’s urology. Octava edición.

  6. Bremnor JD, Sadovsky R. Evaluation of Dysuria in Adults. Am Fam Physician 2002; 65:1589-96, 1597.

  7. Roberts RG, Hartlaub PP. Evaluation of Dysuria in Men. Am Fam Physician 1999; 60: 865-72.

  8. Does this woman have and acute uncomplicated urinary tract infection? JAMA 2002; 287: 2701-2710.

  9. Kurowski K. The woman with dysuria. American Family Physician 1998.

  10. http://www.findarticles.com/cf_dis/m3225/n9_v57/20633618/p1/article.jhtml

  11. Barkham TMS, Martin FC, Eykyn SJ. Delay in the diagnosis of bacteremic urinary tract infection in elderly patients. Age Ageing 1996; 25: 130-132.

  12. Lipsky BA. Managing Prostatitis and Urinary Tract Infection in Men. Antibiotic Research Clinic (S-111M). Veterans Puget Sound Health Care Clinic, 1660 South Columbian Way. Seattle, Washington 98108, USA.

  13. Butler K, Reed KC, Bosker G. New Diagnostic Modalities, Alterations in Drug Resistance Patterns, and Current Antimicrobial Treatment Guidelines for the Hospital and Outpatient Setting. Part I: Diagnosis, Evaluation, and Principles of Antibiotic Selection.

  14. http://www.ahcpub.com/ahc_root_html/hot/sponsored/utipt1.html

  15. N Engl J Med 2003; 349: 259-66.

  16. Clin Infec Dis 2004; 38: 1150-8.

  17. Guidelines of urinary and male genital tract infections of European Association of Urology.

  18. Rodvold KA, Neuhauser M. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy 2001; 21(10 Pt 2): 233S-252S.

  19. Raz R et al. Cranberry juice and urinary tract infection. Clin Infec Dis 2004: (38): 1413.

  20. Carrie AG, Metge CJ. Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women of Manitoba, Canada. Pharmacoepidemiol Drug Saf. 2004. [Epub ahead of print]

  21. Carson C, Naber KG. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 2004; 64(12): 1359-73.

  22. Al-Asmary SM, Al-Helali NS et al. Nosocomial urinary tract infection. Risk factors, rates and trends. Saudi Med J 2004; 25(7): 895-900.

  23. Le J, Briggs GG et al. Urinary tract infections during pregnancy. Ann Pharmacother 2004; 38(10): 1692-701.




2020     |     www.medigraphic.com